Zeke Capital Advisors LLC grew its holdings in shares of Centene Corp (NYSE:CNC) by 30.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,291 shares of the company’s stock after buying an additional 1,004 shares during the period. Zeke Capital Advisors LLC’s holdings in Centene were worth $433,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Elk Creek Partners LLC increased its stake in shares of Centene by 11.5% during the third quarter. Elk Creek Partners LLC now owns 5,264 shares of the company’s stock valued at $509,000 after buying an additional 542 shares during the period. New Mexico Educational Retirement Board increased its stake in shares of Centene by 3.8% during the fourth quarter. New Mexico Educational Retirement Board now owns 16,600 shares of the company’s stock valued at $1,675,000 after buying an additional 600 shares during the period. Eqis Capital Management Inc. increased its stake in shares of Centene by 5.1% during the fourth quarter. Eqis Capital Management Inc. now owns 13,862 shares of the company’s stock valued at $1,398,000 after buying an additional 672 shares during the period. Synovus Financial Corp increased its stake in shares of Centene by 2.3% during the fourth quarter. Synovus Financial Corp now owns 30,363 shares of the company’s stock valued at $3,063,000 after buying an additional 685 shares during the period. Finally, CIBC Asset Management Inc increased its stake in shares of Centene by 4.5% during the fourth quarter. CIBC Asset Management Inc now owns 17,217 shares of the company’s stock valued at $1,737,000 after buying an additional 742 shares during the period. 90.52% of the stock is currently owned by hedge funds and other institutional investors.
In other news, EVP Christopher D. Bowers sold 4,800 shares of the business’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $102.27, for a total value of $490,896.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Jesse N. Hunter sold 10,000 shares of the business’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $98.73, for a total value of $987,300.00. The disclosure for this sale can be found here. Insiders sold 37,300 shares of company stock worth $3,802,509 over the last three months. Corporate insiders own 3.00% of the company’s stock.
Centene stock traded down $0.87 during trading on Monday, reaching $104.74. The company’s stock had a trading volume of 91,452 shares, compared to its average volume of 1,336,626. The company has a quick ratio of 0.93, a current ratio of 0.93 and a debt-to-equity ratio of 0.68. Centene Corp has a twelve month low of $65.03 and a twelve month high of $112.42. The company has a market capitalization of $18,510.54, a P/E ratio of 22.52, a price-to-earnings-growth ratio of 1.02 and a beta of 0.76.
Centene (NYSE:CNC) last released its earnings results on Tuesday, February 6th. The company reported $0.97 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.94 by $0.03. Centene had a return on equity of 13.68% and a net margin of 1.71%. The business had revenue of $12.81 billion for the quarter, compared to the consensus estimate of $12.25 billion. During the same period in the previous year, the company posted $1.19 earnings per share. The company’s revenue for the quarter was up 7.5% compared to the same quarter last year. equities analysts expect that Centene Corp will post 7.2 EPS for the current fiscal year.
Several research firms have recently issued reports on CNC. Leerink Swann restated a “market perform” rating and set a $90.00 price target (down from $100.00) on shares of Centene in a research report on Tuesday, February 13th. Credit Suisse Group lifted their price target on Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a research report on Wednesday, February 7th. Jefferies Group lifted their price target on Centene from $112.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, December 18th. ValuEngine upgraded Centene from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Goldman Sachs assumed coverage on Centene in a research report on Wednesday, January 3rd. They set a “buy” rating and a $135.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $110.28.
TRADEMARK VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/03/19/centene-corp-cnc-shares-bought-by-zeke-capital-advisors-llc.html.
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corp (NYSE:CNC).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.